VTVT: vTv Therapeutics Inc - Class A
今日VTVT汇率已更改-2.00%。当日,交易品种以低点35.7300和高点39.7114进行交易。
关注vTv Therapeutics Inc - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
VTVT新闻
- TD Cowen给予vTv Therapeutics买入评级
- vTv Therapeutics stock initiated with Buy rating at TD Cowen
- This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Lumexa Imaging Holdings (NASDAQ:LMRI), Pinnacle Financial Partners, Inc. Common stock (NYSE:PNFP)
- vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know
- H.C. Wainwright上调vTv Therapeutics目标价至47美元
- vTv Therapeutics stock price target raised to $47 from $36 at H.C. Wainwright
- vTv Therapeutics提交2型糖尿病药物二期临床试验方案
- vTv Therapeutics submits protocol for phase 2 diabetes drug trial
- Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
- Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect?
- All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy
- vTv Therapeutics任命四名新成员加入科学顾问委员会
- vTv Therapeutics appoints four new members to scientific advisory board
- Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Arteris (NASDAQ:AIP), Advanced Micro Devices (NASDAQ:AMD)
- Tracking Baker Brothers Portfolio – Q2 2025 Update
- vTv Therapeutics begins phase 3 trial for type 1 diabetes oral therapy
- Tracking Baker Brothers Portfolio – Q1 2025 Update
- vTv Therapeutics to Participate in the H.C. Wainwright HCW@Home Series
- vTv Therapeutics appoints new CFO amid Phase 3 trial
- vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
- vTv Therapeutics advances type 1 diabetes trial
- This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Mastercard (NYSE:MA), Couchbase (NASDAQ:BASE)
- FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges - vTv Therapeutics (NASDAQ:VTVT)
- vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
常见问题解答
VTVT股票今天的价格是多少?
vTv Therapeutics Inc - Class A股票今天的定价为36.5058。它在35.7300 - 39.7114范围内交易,昨天的收盘价为37.2500,交易量达到53。VTVT的实时价格图表显示了这些更新。
vTv Therapeutics Inc - Class A股票是否支付股息?
vTv Therapeutics Inc - Class A目前的价值为36.5058。股息政策取决于公司,而投资者也会关注78.08%和USD。实时查看图表以跟踪VTVT走势。
如何购买VTVT股票?
您可以以36.5058的当前价格购买vTv Therapeutics Inc - Class A股票。订单通常设置在36.5058或36.5088附近,而53和-3.50%显示市场活动。立即关注VTVT的实时图表更新。
如何投资VTVT股票?
投资vTv Therapeutics Inc - Class A需要考虑年度范围19.8000 - 44.0000和当前价格36.5058。许多人在以36.5058或36.5088下订单之前,会比较-9.05%和。实时查看VTVT价格图表,了解每日变化。
vTv Therapeutics Inc - Class A股票的最高价格是多少?
在过去一年中,vTv Therapeutics Inc - Class A的最高价格是44.0000。在19.8000 - 44.0000内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪vTv Therapeutics Inc - Class A的绩效。
vTv Therapeutics Inc - Class A股票的最低价格是多少?
vTv Therapeutics Inc - Class A(VTVT)的最低价格为19.8000。将其与当前的36.5058和19.8000 - 44.0000进行比较,可以发现潜在的长期切入点。观看VTVT在图表上的实时走势以获取更多详细信息。
VTVT股票是什么时候拆分的?
vTv Therapeutics Inc - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、37.2500和78.08%中可见。
- 前一天收盘价
- 37.2500
- 开盘价
- 37.8300
- 卖价
- 36.5058
- 买价
- 36.5088
- 最低价
- 35.7300
- 最高价
- 39.7114
- 交易量
- 53
- 日变化
- -2.00%
- 月变化
- -9.05%
- 6个月变化
- 78.08%
- 年变化
- 78.08%
- 实际值
- 预测值
- 前值